Role of protein C in renal dysfunction after polymicrobial sepsis

被引:44
作者
Gupta, Akanksha
Berg, David T.
Gerlitz, Bruce
Sharma, Ganesh R.
Syed, Samreen
Richardson, Mark A.
Sandusky, George
Heuer, Josef G.
Galbreath, Elizabeth J.
Grinnell, Brian W.
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Eli Lilly Res Labs, Biotechnol Discovery Res, Indianapolis, IN 46225 USA
[2] Lilly Corp Ctr, Pathol, Eli Lilly Res Labs, Indianapolis, IN USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 03期
关键词
D O I
10.1681/ASN.2006101167
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Protein C (PC) plays an important role in vascular function, and acquired deficiency during sepsis is associated with increased mortality in both animal models and in clinical studies. This study explored the consequences of PC suppression on the kidney in a cecal ligation and puncture model of polymicrobial sepsis. This study shows that a rapid drop in PC after sepsis is strongly associated with an increase in blood urea nitrogen, renal pathology, and expression of known markers of renal injury, including neutrophil gelatinase-associated lipocalin, CXCL1, and CXCL2. The endothelial PC receptor, which is required for the anti-inflammatory and antiapoptotic activity of activated PC (APC), was significantly increased after cecal ligation and puncture as well as in the microvasculature of human kidneys after injury. Treatment of septic animals with APC reduced blood urea nitrogen, renal pathology, and chemokine expression and dramatically reduced the induction of inducible nitric oxide synthase and caspase-3 activation in the kidney. The data demonstrate a clear link between acquired PC deficiency and renal dysfunction in sepsis and suggest a compensatory upregulation of the signaling receptor. Moreover, these data suggest that APC treatment may be effective in reducing inflammatory and apoptotic insult during sepsis-induced acute renal failure.
引用
收藏
页码:860 / 867
页数:8
相关论文
共 55 条
[1]   FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsis [J].
Berg, DT ;
Gerlitz, B ;
Sharma, GR ;
Richardson, MA ;
Stephens, EJ ;
Grubbs, RL ;
Holmes, KC ;
Fynboe, K ;
Montani, D ;
Cramer, MS ;
Engle, SD ;
Jakubowski, JA ;
Heuer, JG ;
Grinnell, BW .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (03) :426-432
[2]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]   Inducible nitric oxide synthase inhibitor reverses exacerbating effects of hypertonic saline on lung injury in burn [J].
Chen, LW ;
Hwang, B ;
Chang, WJ ;
Wang, JS ;
Chen, JS ;
Hsu, CM .
SHOCK, 2004, 22 (05) :472-477
[4]  
Daemen MARC, 2002, TRANSPLANTATION, V73, P1693
[5]   The anticoagulant protein C pathway [J].
Dahlbäck, B ;
Villoutreix, BO .
FEBS LETTERS, 2005, 579 (15) :3310-3316
[6]   Nitric oxide induces apoptosis in renal tubular epithelial cells through activation of caspase-8 [J].
Du, CG ;
Guan, QN ;
Diao, H ;
Yin, ZQ ;
Jevnikar, AM .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (05) :F1044-F1054
[7]   Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation [J].
Dugo, L ;
Marzocco, S ;
Mazzon, E ;
Di Paola, R ;
Genovese, T ;
Caputi, AP ;
Cuzzocrea, S .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (06) :979-987
[8]  
ELACHKAR T, 2001, AM J PHYSIOL-RENAL, V290, pF1034
[9]  
Esmon CT, 1999, HAEMATOLOGICA, V84, P363
[10]  
Esmon CT, 1999, THROMB HAEMOSTASIS, V82, P251